Toxicological implications of esterases - From molecular structures to functions

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 11-18

  Satoh, Tetsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Esterases; Functions; Molecular structure; Xenobiotics

Indexed keywords

ACETYLCHOLINESTERASE; ANESTHETIC AGENT; ARYLDIALKYLPHOSPHATASE; BENAZEPRIL; BIOLOGICAL MARKER; CALCIUM; CAMOSTAT; CARBOXYLESTERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE; CILAZAPRIL; COCAINE; COMPLEMENTARY DNA; DELAPRIL; DIAMORPHINE; DILAZEP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL; IRINOTECAN; ORGANOPHOSPHATE INSECTICIDE; OXYBUTYNIN; PROCAINE; QUINAPRIL; SERINE DEHYDRATASE; SERINE PROTEINASE; TEMOCAPRIL; THYROGLOBULIN; THYROXINE;

AMINO ACID SEQUENCE; BRAIN; CHEMICAL STRUCTURE; CONFERENCE PAPER; DEVELOPMENTAL STAGE; DOG; DRUG HYDROLYSIS; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; FUSARIUM OXYSPORUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INTESTINE; LIVER; MAMMAL; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PHYLOGENETIC TREE; PROTEIN FAMILY; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; STRUCTURAL HOMOLOGY; TOXICOKINETICS; XENOBIOTIC METABOLISM;

EID: 24644469273     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.01.046     Document Type: Conference Paper

References (32)

1. M. Cygler, J.D. Schrag, J.L. Sussman, M. Harel, J. Silman, M.K. Gentry, and B.P. Dector Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases and related proteins Protein Sci. 2 1993 336 382
2. D.I. Draganov, P.L. Stetson, C.E. Watson, S.S. Billecke, and B.N. La Du Rabbit serum paraoxonase 3(P0N3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation J. Biol. Chem. 275 2000 33435 33442
3. P.N. Durrington, B. Mackness, and M.I. Mackness Paraoxonase and atherosclerosis Artheroscler. Thromb. Vasc. Biol. 21 2001 473 474
4. M. Hosokawa, and T. Satoh Differences in the induction of carboxylesterases isozymes in rat liver microsomes by perfluorinated fatty acids Xenobiotica 23 1993 1125 1133
5. M. Hosokawa, T. Maki, and T. Satoh Multiplicity and regulation of hepatic microsomal carboxylesterases in rats Mol. Pharmacol. 31 1987 579 584
6. M. Hosokawa, T. Maki, and T. Satoh Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans Arch. Biophys. 277 1990 219 227
7. M. Hosokawa, K. Hattori, and T. Satoh Differential sequences of responses of rat hepatic microsomal carboxylesterase isozymes to glucocorticoids and pregnenolone 16 α-carbonitrile Biochem. Pharmmacol. 45 1993 2317 2322
8. M. Hosokawa, K. Hirata, F. Nakata, T. Suga, and T. Satoh Species differences in the induction of hepatic microsomal carboxylesterase caused by dietary exposure to di(2-ethylhexyl) phthalate peroxisome proliferator Drug Metab. Dispos. 22 1994 889 894
9. M. Hosokawa, Y. Endo, M. Fujisawa, S. Hara, N. Iwata, Y. Sato, and T. Satoh Interindividual variation in carboxylesterase levels in human liver microsomes Drug Metab. Dispos. 23 1995 1022 1027
10. M. Hosokawa, T. Maki, and T. Satoh Differences in the induction of carboxylesterase isozymes in rat liver microsomes by xenobiotics Biochem. Pharmacol. 37 1998 2708 2711
11. M. Hosokawa, K. Suzuki, D. Takahashi, M. Mori, T. Satoh, and K. Chiba Purification, molecular cloning, and functional expression of dog liver microsomal acyl-CoA hydrolase: a member of the carboxylesterase multigene family Arch. Biochem. Biophys. 389 2001 245 253
12. L.M. Kamendulis, M.R. Brzezinske, E.V. Pindel, W.F. Bosron, and R.S. Dean Metabolism of cocain and heropin is regulated by the same liver carboxylesterases J. Pharmacol. Exp. Ther. 279 1996 713 717
13. M. Kobayashi, M. Shinohara, C. Sakoh, M. Kataoka, and S. Shimizu Lactone ring-cleaving enzyme: genetic analysis, novel RNA editing and evolutionary implications Proc. Natl. Acad. Sci. U.S.A. 95 1999 2787 2792
14. T. Maki, M. Hosokawa, T. Satoh, and K. Sato Changes in carboxylesterase isozymes of rat liver microsomes during hepatocarcinogenesis IPN J. Cancer Res. 82 1991 800 806
15. E.W. Morgan, B. Yan, D. Greenway, D.R. Peterson, and A. Parkinson Purification and characterization of two rat liver carboxylesterases (hydrolase A and B) Arch. Biochem. Biophys. 315 1994 495 512
16. M. Mori, M. Hosokawa, Y. Ogasawara, E. Tsukada, and K. Chiba cDNA cloning, characterization and stable expression of novel human brain carboxylesterase FEBS Lett. 458 1999 17 22
17. C. Mattes, R. Bradley, E. Slaughter, and S. Browne Cocaine and butyrylcholinesterase (BChE). Determination of enzymatic properties Pharmacol. Lett. 58 1996 257 261
18. T.Y. Mynch, C.E. Mattes, A. Singh, R.M. Bradley, R.O. Bradley, and K.L. Dretchen Cocaine detoxification by human plasma butyrylcholinesterase Toxicol. Appl. Pharmacol. 145 1997 363 371
19. S.L. Primo-Parmo, R.S. Sorenson, J. Taiber, and B.N. La Du The human serum paraoxonase-arylesterase gene (PON1) is one member of a multigene family Genomics 33 1996 489 507
20. T. Satoh Release of liver microsomal β-glucuronidase from hepatocytes in vitro and in vivo by organophosphates and hepatotoxic agents J. Toxicol. Sci., Suppl. 1 1991 133 142
21. T. Satoh, and M. Hosokawa Molecular aspects of carboxylesterase isoforms in comparison with other esterases Toxicol. Lett. (Shannon) 82 1995 439 445
22. T. Satoh, and M. Hosokawa The mammalian carboxylesterases: from molecules to functions Annu. Rev. Pharmacol. Toxicol. 38 1998 257 288
23. T. Satoh, and M. Hosokawa Organophosphates and their impact on the global environment Neurotoxicology 21 2000 223 228
24. T. Satoh, M. Hosokawa, R. Atsumi, W. Suzuki, H. Hakusui, and E. Nagai Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidinol] carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase Biochem. Pharm. Bull. 17 1994 662 664
25. T. Satoh, S. Suzuki, N. Kawai, T. Nakamura, and M. Hosokawa Toxicological significance in the cleavage of esterase-β-glucuronidase complex in liver microsomes by organophosphorus compounds, 1999 Chem.-Biol. Interact. 119-120 1999 471 478
26. T. Satoh, P. Taylor, W.F. Bosron, S.P. Sanghani, M. Hosokawa, and B. La Du Current progress on esterases: from molecular structure to function Drug Metab. Dispos. 30 2002 488 493
27. M. Schumacher, S. Camp, Y. Maulet, M. Newton, K. MacPhee-Quigley, T. Friedman, S. Taylor, and P. Taylor Primary structure of Torpedo californica acetylcholinesterase deduced from cDNA sequences Nature (London) 319 1986 407 409
28. D.M. Shih, L. Gu, Y.R. Xia, M. Navab, W.F. Li, S. Hama, L.W. Castellani, C.E. Furlong, L.G. Costa, and A.M. Fogelman Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature (London) 394 1998 284 287
29. S. Swillens, M. Ludgate, L. Merchen, J.E. Dumont, and G. Vassart Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase possible functional and clinical significance Biochem. Biophys. Res. Commun. 137 1986 142 148
30. H. Takayama, A. Watanabe, M. Hosokawa, K. Chiba, T. Satoh, and N. Aimi Synthesis of new class of camptotecin derivatives the long chain fatty acid esters of 10-hydroxycamptothecin, and a potent prodrug candidate, and their in vitro metabolic conversion by carboxylesterases Bioorg. Med. Chem. Lett. 8 1998 415 418
31. S. Takai, A. Matsuda, Y. Usami, T. Adachi, T. Sugiyama, Y. Katagiti, M. Tatematsu, and K. Hirano Hydrolytic profile for ester- or amide-linkage by carboxylesterase pI 5.3 and 4.5 from human liver Biol. Pharm. Bull. 20 1997 869 873
32. T. Yamada, M. Hosokawa, T. Satoh, I. Moroo, M. Takahashi, H. Akatsu, and T. Yamamaoto Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissues Brain Res. 658 1994 163 167